{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T11:12:45Z","timestamp":1778584365004,"version":"3.51.4"},"reference-count":37,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,11,16]],"date-time":"2023-11-16T00:00:00Z","timestamp":1700092800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82071848"],"award-info":[{"award-number":["82071848"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81773488"],"award-info":[{"award-number":["81773488"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cytokine"],"published-print":{"date-parts":[[2024,1]]},"DOI":"10.1016\/j.cyto.2023.156442","type":"journal-article","created":{"date-parts":[[2023,11,22]],"date-time":"2023-11-22T14:06:20Z","timestamp":1700661980000},"page":"156442","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["Cytokine profiles and virological markers highlight distinctive immune statuses, and effectivenesses and limitations of NAs across different courses of chronic HBV infection"],"prefix":"10.1016","volume":"173","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3196-4462","authenticated-orcid":false,"given":"Lixin","family":"Xiao","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kang","family":"Tang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ting","family":"Fu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaojie","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Samuel","family":"Seery","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Weilu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhaohua","family":"Ji","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhen","family":"He","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yan","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wenhua","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wenling","family":"Jia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chunhui","family":"Liang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haitao","family":"Tang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fengmei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yancheng","family":"Ye","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lihua","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhongjun","family":"Shao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.cyto.2023.156442_b0005","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/j.jhep.2019.11.003","article-title":"EASL-AASLD HBV treatment endpoints conference(\u2021)","volume":"72","author":"Cornberg","year":"2020","journal-title":"J Hepatol."},{"key":"10.1016\/j.cyto.2023.156442_b0010","unstructured":"Fact-sheet: Hepatitis B [internet]. Geneva: World Health Organization; 2022. Available from: https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/hepatitis-b."},{"issue":"10","key":"10.1016\/j.cyto.2023.156442_b0015","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1038\/s41575-019-0197-8","article-title":"Clinical utility of HBV surface antigen quantification in HBV e antigen-negative chronic HBV infection","volume":"16","author":"Liaw","year":"2019","journal-title":"Nat Rev Gastroenterol Hepatol."},{"key":"10.1016\/j.cyto.2023.156442_b0020","doi-asserted-by":"crossref","first-page":"230","DOI":"10.2471\/BLT.18.219469","article-title":"Countdown to 2030: eliminating hepatitis B disease, China","volume":"97","author":"Liu","year":"2019","journal-title":"Bull. World Health Organ."},{"issue":"27","key":"10.1016\/j.cyto.2023.156442_b0025","doi-asserted-by":"crossref","first-page":"3527","DOI":"10.3748\/wjg.v25.i27.3527","article-title":"Immune suppression in chronic hepatitis B infection associated liver disease: A review","volume":"25","author":"Li","year":"2019","journal-title":"World J Gastroenterol."},{"key":"10.1016\/j.cyto.2023.156442_b0030","doi-asserted-by":"crossref","first-page":"S765","DOI":"10.1093\/infdis\/jix356","article-title":"Immunopathogenesis of hepatitis B virus","volume":"216","author":"Tseng","year":"2017","journal-title":"J Infect Dis."},{"issue":"1","key":"10.1016\/j.cyto.2023.156442_b0035","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1038\/s41577-021-00549-4","article-title":"Immunobiology and pathogenesis of hepatitis B virus infection","volume":"22","author":"Iannacone","year":"2022","journal-title":"Nat. Rev. Immunol."},{"issue":"6","key":"10.1016\/j.cyto.2023.156442_b0040","doi-asserted-by":"crossref","first-page":"1778","DOI":"10.1053\/j.gastro.2018.01.034","article-title":"Hepatitis B virus does not interfere with innate immune responses in the human liver","volume":"154","author":"Suslov","year":"2018","journal-title":"Gastroenterology."},{"key":"10.1016\/j.cyto.2023.156442_b0045","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.1025654","article-title":"Describing immune factors associated with Hepatitis B surface antigen loss: A nested case-control study of a Chinese sample from Wuwei City","volume":"13","author":"Yuan","year":"2022","journal-title":"Front Immunol."},{"key":"10.1016\/j.cyto.2023.156442_b0050","first-page":"769","article-title":"Guidelines for prevention and treatment of chronic hepatitis B","volume":"9","author":"Wang","year":"2021","journal-title":"J Clin Transl Hepatol."},{"issue":"1","key":"10.1016\/j.cyto.2023.156442_b0055","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-017-11975-7","article-title":"Differential serum cytokine profiles in patients with chronic hepatitis B, C, and hepatocellular carcinoma","volume":"7","author":"Estevez","year":"2017","journal-title":"Sci Rep."},{"key":"10.1016\/j.cyto.2023.156442_b0060","doi-asserted-by":"crossref","first-page":"28","DOI":"10.14712\/fb2021067010028","article-title":"Serum cytokine analysis reveals predictors of progression from chronic hepatitis B to liver cirrhosis","volume":"67","author":"Cai","year":"2021","journal-title":"Folia Biol (praha)."},{"issue":"1","key":"10.1016\/j.cyto.2023.156442_b0065","doi-asserted-by":"crossref","DOI":"10.1186\/s13020-015-0055-8","article-title":"Serum cytokine profiling analysis for zheng differentiation in chronic hepatitis B","volume":"10","author":"Lu","year":"2015","journal-title":"Chin Med."},{"key":"10.1016\/j.cyto.2023.156442_b0070","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2019.00006","article-title":"LAYN is a prognostic biomarker and correlated with immune infiltrates in gastric and colon cancers","volume":"10","author":"Pan","year":"2019","journal-title":"Front Immunol."},{"issue":"13","key":"10.1016\/j.cyto.2023.156442_b0075","doi-asserted-by":"crossref","first-page":"7151","DOI":"10.1111\/jcmm.15164","article-title":"TGF\u03b22 is a prognostic-related biomarker and correlated with immune infiltrates in gastric cancer","volume":"24","author":"Xiao","year":"2020","journal-title":"J Cell Mol Med."},{"key":"10.1016\/j.cyto.2023.156442_b0080","unstructured":"European Association for the Study of the Liver. Electronic address eee European Association for the Study of the L. EASL 2017 Clinical Practice Guidelines on the management of hepatitis B virus infection. J Hepatol 67 2017 370 398."},{"key":"10.1016\/j.cyto.2023.156442_b0085","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.3892\/etm.2014.1533","article-title":"Serum IL-21 levels associated with chronic hepatitis B and hepatitis B-related liver failure","volume":"7","author":"Chen","year":"2014","journal-title":"Exp Ther Med."},{"key":"10.1016\/j.cyto.2023.156442_b0090","doi-asserted-by":"crossref","first-page":"753","DOI":"10.4049\/jimmunol.1101652","article-title":"Upregulation of IL-23 expression in patients with chronic hepatitis B is mediated by the HBx\/ERK\/NF-\u03baB pathway","volume":"188","author":"Xia","year":"2012","journal-title":"J Immunol."},{"issue":"2","key":"10.1016\/j.cyto.2023.156442_b0095","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.clinre.2016.10.005","article-title":"Role of interleukin-23 in monocyte-derived dendritic cells of HBV-related acute-on-chronic liver failure and its correlation with the severity of liver damage","volume":"41","author":"Bao","year":"2017","journal-title":"Clin Res Hepatol Gastroenterol."},{"issue":"4","key":"10.1016\/j.cyto.2023.156442_b0100","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1016\/j.immuni.2019.03.012","article-title":"Interleukin-1 and related cytokines in the regulation of inflammation and immunity (IL-33)","volume":"50","author":"Mantovani","year":"2019","journal-title":"Immunity."},{"issue":"20","key":"10.1016\/j.cyto.2023.156442_b0105","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.122268","article-title":"Cytokine and chemokine signatures associated with hepatitis B surface antigen loss in hepatitis B patients","volume":"3","author":"Yoshio","year":"2018","journal-title":"JCI Insight."},{"key":"10.1016\/j.cyto.2023.156442_b0110","doi-asserted-by":"crossref","first-page":"12159","DOI":"10.1074\/jbc.M109.067629","article-title":"Hepatitis B virus protein X-induced expression of the CXC chemokine IP-10 is mediated through activation of NF-kappaB and increases migration of leukocytes","volume":"285","author":"Zhou","year":"2010","journal-title":"J Biol Chem."},{"key":"10.1016\/j.cyto.2023.156442_b0115","unstructured":"Single cell sequencing results of CXCL9, CXCL10 and CXCL11 in the liver. Available from: https:\/\/www.proteinatlas.org\/ENSG00000138755-CXCL9\/single+cell+type\/liver and https:\/\/www.proteinatlas.org\/ENSG00000169248-CXCL11\/single+cell+type\/liver."},{"key":"10.1016\/j.cyto.2023.156442_b0120","doi-asserted-by":"crossref","first-page":"100302","DOI":"10.1016\/j.mtbio.2022.100302","article-title":"Proteomic characterization of the natural history of chronic HBV infection revealed by tandem mass tag-based quantitative proteomics approach","volume":"15","author":"Xun","year":"2022","journal-title":"Mater Today Bio."},{"issue":"1","key":"10.1016\/j.cyto.2023.156442_b0125","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1002\/hep.27805","article-title":"Re-evaluation of hepatitis B virus clinical phases by systems biology identifies unappreciated roles for the innate immune response and B cells","volume":"62","author":"Vanwolleghem","year":"2015","journal-title":"Hepatology."},{"key":"10.1016\/j.cyto.2023.156442_b0130","first-page":"147","article-title":"Activated lymphocytes and high liver expression of IFN-\u03b3 are associated with fulminant hepatic failure in patients","volume":"32","author":"dos Santos","year":"2012","journal-title":"LiverInt."},{"key":"10.1016\/j.cyto.2023.156442_b0135","doi-asserted-by":"crossref","first-page":"2048","DOI":"10.3389\/fimmu.2019.02048","article-title":"HBV-induced immune imbalance in the development of HCC","volume":"10","author":"Chen","year":"2019","journal-title":"Front Immunol."},{"issue":"2","key":"10.1016\/j.cyto.2023.156442_b0140","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1007\/s12253-019-00585-5","article-title":"Current status and perspective biomarkers in AFP negative HCC: Towards screening for and diagnosing hepatocellular carcinoma at an earlier stage","volume":"26","author":"Luo","year":"2020","journal-title":"Pathol Oncol Res."},{"issue":"3","key":"10.1016\/j.cyto.2023.156442_b0145","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1002\/hep.32185","article-title":"GALAD demonstrates high sensitivity for HCC surveillance in a cohort of patients with cirrhosis","volume":"75","author":"Singal","year":"2022","journal-title":"Hepatology."},{"key":"10.1016\/j.cyto.2023.156442_b0150","doi-asserted-by":"crossref","DOI":"10.3390\/ph14080735","article-title":"GALAD score detects early-stage hepatocellular carcinoma in a european cohort of chronic hepatitis B and C patients","volume":"14","author":"Schotten","year":"2021","journal-title":"Pharmaceuticals (Basel)."},{"issue":"4","key":"10.1016\/j.cyto.2023.156442_b0155","doi-asserted-by":"crossref","first-page":"101099","DOI":"10.1016\/j.aohep.2023.101099","article-title":"Comparison of diagnostic performance of AFP, DCP and two diagnostic models in hepatocellular carcinoma: A retrospective study","volume":"28","author":"Chen","year":"2023","journal-title":"Ann Hepatol."},{"key":"10.1016\/j.cyto.2023.156442_b0160","doi-asserted-by":"crossref","first-page":"1018396","DOI":"10.3389\/fonc.2022.1018396","article-title":"ASAP Score versus GALAD Score for detection of hepatitis C-related hepatocellular carcinoma: A multicenter case-control analysis","volume":"12","author":"Liu","year":"2022","journal-title":"Front Oncol."},{"key":"10.1016\/j.cyto.2023.156442_b0165","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.cyto.2016.08.016","article-title":"CXCL13 rather than IL-31 is a potential indicator in patients with hepatocellular carcinoma","volume":"89","author":"Li","year":"2017","journal-title":"Cytokine."},{"key":"10.1016\/j.cyto.2023.156442_b0170","first-page":"345413","article-title":"The effect of C-X-C motif chemokine 13 on hepatocellular carcinoma associates with wnt signaling","volume":"2015","author":"Li","year":"2015","journal-title":"Biomed Res Int."},{"issue":"12","key":"10.1016\/j.cyto.2023.156442_b0175","doi-asserted-by":"crossref","first-page":"14405","DOI":"10.18632\/oncotarget.7360","article-title":"An alternatively spliced variant of CXCR3 mediates the metastasis of CD133+ liver cancer cells induced by CXCL9","volume":"7","author":"Ding","year":"2016","journal-title":"Oncotarget."},{"issue":"6","key":"10.1016\/j.cyto.2023.156442_b0180","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1007\/s10735-014-9593-0","article-title":"The effect of CXCL9 on the invasion ability of hepatocellular carcinoma through up-regulation of PREX2","volume":"45","author":"Lan","year":"2014","journal-title":"J Mol Histol."},{"issue":"5","key":"10.1016\/j.cyto.2023.156442_b0185","doi-asserted-by":"crossref","first-page":"2169","DOI":"10.21037\/tcr-21-127","article-title":"Functions of CXC chemokines as biomarkers and potential therapeutic targets in the hepatocellular carcinoma microenvironment","volume":"10","author":"Wang","year":"2021","journal-title":"Transl Cancer Res."}],"container-title":["Cytokine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043466623003204?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043466623003204?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T10:30:24Z","timestamp":1778581824000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1043466623003204"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1]]},"references-count":37,"alternative-id":["S1043466623003204"],"URL":"https:\/\/doi.org\/10.1016\/j.cyto.2023.156442","relation":{},"ISSN":["1043-4666"],"issn-type":[{"value":"1043-4666","type":"print"}],"subject":[],"published":{"date-parts":[[2024,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cytokine profiles and virological markers highlight distinctive immune statuses, and effectivenesses and limitations of NAs across different courses of chronic HBV infection","name":"articletitle","label":"Article Title"},{"value":"Cytokine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cyto.2023.156442","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"156442"}}